Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 4/2/2016 |
| Start Date: | December 2007 |
| End Date: | September 2008 |
| Contact: | Lenworth N Johnson, MD |
| Email: | johnsonln@health.missouri.edu |
| Phone: | 573-882-8470 |
The purpose of this study is to determine whether a homeopathic therapy in combination with
cyclosporin (Restasis) is more effective than cyclosporin (Restasis) alone in the treatment
of dry eye disease.
cyclosporin (Restasis) is more effective than cyclosporin (Restasis) alone in the treatment
of dry eye disease.
Dry eye disease affects millions of people world-wide, and presents with symptoms of blurred
vision, discharge from the eyes, eye discomfort, burning, redness, sandy and gritty feeling
in the eyes, and sensitivity to light. Topical eye drops for eye lubrication (i.e.,
artificial tear solutions) and controlling ocular inflammation through the use of topical
immunomodulatory agents (i.e., cyclosporine [Restasis]) have been shown to be effective for
treating dry eye syndrome, but are not curative. Recently, we have evaluated a few patients
who had discontinued using Restasis as they had obtained better relief of their dry eye
symptoms with a homeopathic therapy.
Potential participants will undergo an eye examination consisting of medical history and
physical examination (i.e., visual acuity, pupillary exam, examination of the lids,
slit-lamp examination of the conjunctiva, cornea, anterior chamber, iris, and lens, and
funduscopic examination). Participants qualifying for the study will then stop all eye
medications and will use a common artificial tear solution for 2 weeks prior to the baseline
examination. We will evaluate 4 measures of dry eyes at baseline and after 6 weeks of
therapy: 1) tear film to break-up; 2) staining of the cornea by fluorescein stain; 3)
measurement of tear production over 5 minutes by Schirmer's test; and 4) the Ocular Surface
Disease Index (OSDI).
vision, discharge from the eyes, eye discomfort, burning, redness, sandy and gritty feeling
in the eyes, and sensitivity to light. Topical eye drops for eye lubrication (i.e.,
artificial tear solutions) and controlling ocular inflammation through the use of topical
immunomodulatory agents (i.e., cyclosporine [Restasis]) have been shown to be effective for
treating dry eye syndrome, but are not curative. Recently, we have evaluated a few patients
who had discontinued using Restasis as they had obtained better relief of their dry eye
symptoms with a homeopathic therapy.
Potential participants will undergo an eye examination consisting of medical history and
physical examination (i.e., visual acuity, pupillary exam, examination of the lids,
slit-lamp examination of the conjunctiva, cornea, anterior chamber, iris, and lens, and
funduscopic examination). Participants qualifying for the study will then stop all eye
medications and will use a common artificial tear solution for 2 weeks prior to the baseline
examination. We will evaluate 4 measures of dry eyes at baseline and after 6 weeks of
therapy: 1) tear film to break-up; 2) staining of the cornea by fluorescein stain; 3)
measurement of tear production over 5 minutes by Schirmer's test; and 4) the Ocular Surface
Disease Index (OSDI).
Inclusion Criteria:
- diagnosis of moderate to severe dry eye syndrome with or without Sjögren's syndrome
- receiving treatment with topical cyclosporine (Restasis)
- experience one or more moderate dry eye-related symptoms, including dryness, foreign
body sensation, burning, blurred vision, photophobia, and soreness or pain
Exclusion Criteria:
- history of ocular disorder including non-dry eye ocular inflammation, glaucoma,
contact lens use
- trauma or surgery, including punctal plug insertion within the prior 3 months
- any uncontrolled systemic disease or significant illness
- use of topical ophthalmic medications that could affect dry eye syndrome
- pregnancy, lactation, or considering a pregnancy
We found this trial at
1
site
Click here to add this to my saved trials
